Patents by Inventor Yongli Xie

Yongli Xie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11939681
    Abstract: A a plant composite corrosion inhibitor for an oil field and a preparation method thereof belong to the technical field of preparation of oil field chemical agents. The plant composite corrosion inhibitor comprises a first plant ingredient, a second plant ingredient, a corrosion inhibition synergist and an organic solvent. The first plant ingredient is zeaxanthin and a derivative thereof obtained by supercritical CO2 extraction of marigold; the second plant ingredient is prepared from luffa leaves, guava leaves and eclipta according to a mass ratio of 5:8:9; the corrosion inhibition synergist is prepared by mixing potassium iodide, 8-hydroxyquinoline and sodium dodecyl benzene sulfonate according to a mass ratio of 3:4:2; and the organic solvent is ethanol with a mass concentration of 82%. The composite corrosion inhibitor has a good corrosion inhibition effect, and reduces harmful chemical ingredients in the corrosion inhibitor.
    Type: Grant
    Filed: September 18, 2023
    Date of Patent: March 26, 2024
    Assignee: Southwest Petroleum University
    Inventors: San He, YongLi Zou, XinYue Cai, YueYing Zhao, MengYu Xie, AnLin Yao, ZongMing Yuan
  • Patent number: 7470666
    Abstract: The present invention relates to use of Ulinastatin and its pharmaceutical composition for treating and/or preventing Severe Acute Respiratory Syndrome (SARS). Ulinastatin is effective for treating and/or preventing SARS, particularly Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS). Ulinastatin is generally used as the pharmaceutical composition, preferably in the form of freeze-dried powder or aqueous solution for injection.
    Type: Grant
    Filed: May 25, 2004
    Date of Patent: December 30, 2008
    Assignee: Guangdong Techpool Biochem. Pharma. Co., Ltd.
    Inventors: Heliang Fu, Piqu Miao, Xiaoyan Wang, Yongli Xie
  • Publication number: 20070275879
    Abstract: The present invention relates to use of Ulinastatin and its pharmaceutical composition for treating and/or preventing Severe Acute Respiratory Syndrome (SARS). Ulinastatin is effective for treating and/or preventing SARS, particularly Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS). Ulinastatin is generally used as the pharmaceutical composition, preferably in the form of freeze-dried powder or aqueous solution for injection.
    Type: Application
    Filed: May 25, 2004
    Publication date: November 29, 2007
    Inventors: Heliang Fu, Piqu Miao, Yongli Xie